Rhumbline Advisers Grows Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Rhumbline Advisers lifted its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 0.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 76,582 shares of the company’s stock after buying an additional 484 shares during the quarter. Rhumbline Advisers’ holdings in Phibro Animal Health were worth $1,608,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. New York State Teachers Retirement System raised its position in Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after buying an additional 775 shares during the last quarter. Smith Group Asset Management LLC acquired a new position in shares of Phibro Animal Health during the fourth quarter worth about $541,000. Inspire Investing LLC purchased a new stake in Phibro Animal Health in the 4th quarter valued at approximately $791,000. SG Americas Securities LLC boosted its holdings in Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after purchasing an additional 906 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after purchasing an additional 27,201 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Wall Street Analysts Forecast Growth

PAHC has been the subject of a number of analyst reports. Morgan Stanley increased their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. StockNews.com downgraded shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Finally, Barclays raised their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Stock Performance

Shares of PAHC opened at $24.07 on Wednesday. The company’s 50 day simple moving average is $22.35 and its 200 day simple moving average is $22.43. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company has a market capitalization of $974.91 million, a price-to-earnings ratio of 50.15, a PEG ratio of 0.45 and a beta of 0.52. Phibro Animal Health Co. has a 1 year low of $11.98 and a 1 year high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, sell-side analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.